Titelia

Holdings of Affinity Asset Advisors, LLC

· Original filing · Compare with another fund · Report an error

Net assets
-
Positions
76 in 6 countries
Top ten
46.5 % of the equity sleeve
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
1Apogee Therapeutics Inc 1,284,926108.2M $
2Erasca Inc 5,350,00086.6M $
3Insmed Inc 480,00078.5M $
4Spyre Therapeutics Inc 1,279,13464.5M $
5Centessa Pharmaceuticals PLC 1,400,00055.6M $
6Praxis Precision Medicines Inc 170,00054.8M $
7AnaptysBio Inc 940,00052.1M $
8CYTOKINETICS INC 700,48346.2M $
9ABIVAX SA 405,00045.1M $
10Teva Pharmaceutical Industries Ltd 1,400,00042.2M $
11ARCELLX INC 362,76441.7M $
12Nuvalent Inc 300,00030.7M $
13Terns Pharmaceuticals Inc 562,63129.7M $
14Dianthus Therapeutics Inc 350,00029.4M $
15Lexeo Therapeutics Inc 5,050,21129M $
16COGENT BIOSCIENCES INC 750,00028.9M $
17Madrigal Pharmaceuticals Inc 55,00028.8M $
18Sutro Biopharma Inc 1,069,51926.6M $
19Forte Biosciences Inc 1,011,89026.2M $
20ORUKA THERAPEUTICS INC 499,67324.5M $
21Trevi Therapeutics Inc 2,000,17223.9M $
22Ovid therapeutics Inc 10,636,31823.6M $
23Enliven Therapeutics Inc 586,90423M $
24ASCENDIS PHARMA A/S 95,00021.7M $
25Mineralys Therapeutics Inc 750,00020.3M $
26AVALO THERAPEUTICS INC 1,340,84020M $
27Protagonist Therapeutics Inc 172,12518.1M $
28Celldex Therapeutics Inc 500,00015.9M $
29Nurix Therapeutics Inc 967,62015M $
30SAVARA INC 2,512,15313.7M $
31Perspective Therapeutics Inc 3,164,58213.2M $
32Arrowhead Pharmaceuticals Inc 200,00012.5M $
33DAMORA THERAPEUTICS INC 450,00011.7M $
34Alto Neuroscience Inc 500,00011.2M $
35Bridgebio Pharma Inc 150,00011.1M $
36Cullinan Therapeutics Inc 781,26011.1M $
37BELITE BIO INC 65,00010.4M $
38VERA THERAPEUTICS INC 250,00010.1M $
39TYRA BIOSCIENCES INC 257,5129.9M $
40REVOLUTION MEDICINES INC 100,0009.7M $
41JADE BIOSCIENCES INC 639,9569M $
42TRAVERE THERAPEUTICS INC 300,0008.9M $
43Korro Bio Inc 706,9048M $
44SpyGlass Pharma Inc 250,0006.5M $
45COMPASS PATHWAYS PLC 1,108,4836.1M $
46iBio Inc 3,107,2005.9M $
47ANTERIS TECHNOLOGIES GLOBAL CORP 912,3975.1M $
48VIRIDIAN THERAPEUTICS INC 250,0004.9M $
49Climb Bio Inc 700,0004.8M $
50Rezolute Inc 1,547,6414.7M $
51Sagimet Biosciences Inc 868,0204.5M $
52MBX BIOSCIENCES INC 150,0004.5M $
53Taysha Gene Therapies Inc 1,000,0004.5M $
54VERADERMICS INC 70,0004.4M $
55Generate Biomedicines Inc 350,0004.4M $
56ArriVent Biopharma Inc 175,0004M $
57Relay Therapeutics Inc 400,0004M $
58Verrica Pharmaceuticals Inc 707,3383.7M $
59Precision BioSciences Inc 597,9463.3M $
60KARYOPHARM THERAPEUTICS INC 500,0002.8M $
61Crinetics Pharmaceuticals Inc 75,0002.7M $
62NEXTCURE INC 241,8262.6M $
63IMMUNOVANT INC 100,0002.5M $
64Equillium Inc 1,226,3102.5M $
65SAB Biotherapeutics Inc 575,0002.2M $
66Corcept Therapeutics Inc 50,0002M $
67Orchestra BioMed Holdings Inc 402,5501.7M $
68Kezar Life Sciences Inc 229,0761.7M $
69MacroGenics Inc 500,0001.4M $
70ADLAI NORTYE LTD 164,7481.1M $
71Alector Inc 500,0001.1M $
72OnKure Therapeutics Inc 240,963997.6K $
73LENZ Therapeutics Inc 100,000915K $
74X4 Pharmaceuticals Inc 145,000598.9K $
75Q32 Bio Inc 27,777178.3K $
76ADAGIO MEDICAL HOLDINGS INC 80,00092K $

Download this table: CSV, JSON

Tell me about updates

Sector breakdown

  • Health care 5.8 %
  • Unattributed 94.2 %

Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".

Currency breakdown

  • USD 100.0 %

Each line is counted in its quoted currency, as the fund declares it.

Country breakdown

  • United States 86.6 %
  • United Kingdom 4.5 %
  • France 3.3 %
  • Israel 3.1 %
  • Denmark 1.6 %
  • Cayman Islands 0.8 %

Shares are computed on the fund's equities only.

RankCountryLinesValueShare
1United States691.2B $86.64 %
2United Kingdom261.7M $4.53 %
3France145.1M $3.31 %
4Israel142.2M $3.09 %
5Denmark121.7M $1.59 %
6Cayman Islands211.5M $0.84 %
Cite this page

Titelia. "Holdings of Affinity Asset Advisors, LLC". https://titelia.com/en/funds/US13F1773195